Dyfyniad APA

Chen, E., Brown, D. M., Wong, T. P., Benz, M. S., Kegley, E., Cox, J., . . . Kim, R. Y. (2010). Lucentis(®) using Visudyne(®) study: Determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration. Dove Medical Press.

Dyfyniad Arddull Chicago

Chen, Eric, David M. Brown, Tien P. Wong, Matthew S. Benz, Eric Kegley, Joel Cox, Richard H. Fish, and Rosa Y. Kim. Lucentis(®) Using Visudyne(®) Study: Determining the Threshold-dose Fluence of Verteporfin Photodynamic Therapy Combined With Intravitreal Ranibizumab for Exudative Macular Degeneration. Dove Medical Press, 2010.

Dyfyniad MLA

Chen, Eric, et al. Lucentis(®) Using Visudyne(®) Study: Determining the Threshold-dose Fluence of Verteporfin Photodynamic Therapy Combined With Intravitreal Ranibizumab for Exudative Macular Degeneration. Dove Medical Press, 2010.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.